NZ208023A - Heterocyclic fluoroalkoxy compounds and pharmaceutical compositions - Google Patents

Heterocyclic fluoroalkoxy compounds and pharmaceutical compositions

Info

Publication number
NZ208023A
NZ208023A NZ208023A NZ20802384A NZ208023A NZ 208023 A NZ208023 A NZ 208023A NZ 208023 A NZ208023 A NZ 208023A NZ 20802384 A NZ20802384 A NZ 20802384A NZ 208023 A NZ208023 A NZ 208023A
Authority
NZ
New Zealand
Prior art keywords
methoxy
methyl
benzimidazole
compounds
represents hydrogen
Prior art date
Application number
NZ208023A
Other languages
English (en)
Inventor
G Rainer
R Riedel
J Senn-Bilfinger
K Klemm
H Schaefer
V Figala
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of NZ208023A publication Critical patent/NZ208023A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Heat Treatment Of Sheet Steel (AREA)
NZ208023A 1983-05-03 1984-05-02 Heterocyclic fluoroalkoxy compounds and pharmaceutical compositions NZ208023A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH240183 1983-05-03

Publications (1)

Publication Number Publication Date
NZ208023A true NZ208023A (en) 1987-07-31

Family

ID=4232920

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ208023A NZ208023A (en) 1983-05-03 1984-05-02 Heterocyclic fluoroalkoxy compounds and pharmaceutical compositions

Country Status (17)

Country Link
US (1) US4555518A (en, 2012)
EP (1) EP0134400B1 (en, 2012)
JP (2) JPS59206379A (en, 2012)
KR (1) KR840009098A (en, 2012)
AT (1) ATE87311T1 (en, 2012)
AU (1) AU579316B2 (en, 2012)
DE (1) DE3486109D1 (en, 2012)
DK (1) DK217184A (en, 2012)
ES (2) ES8604927A1 (en, 2012)
FI (1) FI841759L (en, 2012)
GR (1) GR79849B (en, 2012)
HU (1) HU195220B (en, 2012)
IL (1) IL71664A (en, 2012)
NO (1) NO841754L (en, 2012)
NZ (1) NZ208023A (en, 2012)
PT (1) PT78518B (en, 2012)
ZA (1) ZA843288B (en, 2012)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW4585A1 (en) * 1984-04-19 1985-11-20 Hoffmann La Roche Imidazole derivatives
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
GB8417194D0 (en) * 1984-07-05 1984-08-08 Boots Co Plc Therapeutic agents
JPS6150979A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
DE3430513A1 (de) * 1984-08-18 1986-02-27 Wella Ag, 6100 Darmstadt Haarfaerbemittel mit diamino-tetrafluorethoxybenzolen sowie neue diamino-tetrafluorethoxybenzole
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US4738975A (en) * 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
JPS6261978A (ja) * 1985-09-12 1987-03-18 Otsuka Pharmaceut Co Ltd ５−フルオロ−１ｈ−ベンズイミダゾ−ル誘導体
DE3621215A1 (de) * 1986-06-25 1988-01-07 Bayer Ag Fluorhaltige o-phenylendiamine und o-aminophenole
JPH0643426B2 (ja) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
FI96860C (fi) * 1987-06-17 1996-09-10 Eisai Co Ltd Analogiamenetelmä lääkeaineena käytettävän pyridiinijohdannaisen valmistamiseksi
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
AU3690289A (en) * 1988-05-25 1989-12-12 Byk Gulden Lomberg Chemische Fabrik Gmbh New fluoralkoxy compounds
US5223515A (en) * 1988-08-18 1993-06-29 Takeda Chemical Industries, Ltd. Injectable solution containing a pyridyl methylsulfinylbenzimidazole
AT391693B (de) * 1988-11-15 1990-11-12 Cl Pharma Verfahren zur herstellung von 3-5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer
SE8804628D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New compounds
IE64199B1 (en) * 1988-12-22 1995-07-12 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
ES2166811T3 (es) 1993-12-01 2002-05-01 Byk Gulden Lomberg Chem Fab Amino-alquil-amino-piridinas sustituidas.
ES2236628T3 (es) * 1995-09-21 2005-07-16 Pharma Pass Ii Llc Composicion farmaceutica que contiene un omeprazol labil de acido, y procedimiento para su preparacion.
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
ES2171116B1 (es) * 2000-04-14 2003-08-01 Esteve Quimica Sa Procedimiento para la obtencion de derivados de (((piridil sustituido)metil)tio)bencimidazol.
US20020064555A1 (en) * 2000-09-29 2002-05-30 Dan Cullen Proton pump inhibitor formulation
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
EP1572680A2 (en) * 2002-12-19 2005-09-14 Eva Pharmaceutical Industries Ltd. Solid states of pantoprazole sodium, known pantoprazole sodium hydrates, processes for their preparation.
NZ541373A (en) * 2003-01-15 2008-11-28 Cipla Ltd Pharmaceutical process for preparing sulfinyl compounds by oxidation of sulfide compounds that are useful as proton pump inhibitors
US20040235904A1 (en) * 2003-03-12 2004-11-25 Nina Finkelstein Crystalline and amorphous solids of pantoprazole and processes for their preparation
US7683177B2 (en) * 2003-06-10 2010-03-23 Teva Pharmaceutical Industries Ltd Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4045564A (en) * 1974-02-18 1977-08-30 Ab Hassle Benzimidazole derivatives useful as gastric acid secretion inhibitors
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
LU77115A1 (en, 2012) * 1977-04-12 1979-01-18
LU77125A1 (en, 2012) * 1977-04-12 1979-01-18
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IT1119096B (it) * 1978-06-05 1986-03-03 Sankyo Co Derivati della benzotiazocina e della benzotiazonina particolarmente utili come medicamenti e procedimento per la loro preparazione
CH642359A5 (en) * 1978-10-02 1984-04-13 Ciba Geigy Ag Benzimidazole derivatives
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
IL66340A (en) * 1981-08-13 1986-08-31 Haessle Ab Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation
IE57646B1 (en) * 1983-12-16 1993-02-10 Wyeth John & Brother Ltd Derivatives of imidazoquinolines and analogues thereof
GB8526154D0 (en) * 1985-02-06 1985-11-27 Kotobuki Seiyaku Co Ltd 2-substituted cyclo-heptoimidazoles
KR950001015B1 (ko) * 1986-01-10 1995-02-07 닛뽕 케미화 가부시끼가이샤 술폭시드 유도체의 제조방법
FR2597478B1 (fr) * 1986-04-21 1988-12-16 Esteve Labor Dr Benzimidazoles et imidazopyridines sulfonamides, leur preparation et leur application en tant que medicaments.
EP0251536A1 (en) * 1986-06-24 1988-01-07 FISONS plc Benzimidazoles, their production, formulation and use as gastric acid secretion inhibitors
JPH0643426B2 (ja) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤

Also Published As

Publication number Publication date
FI841759A7 (fi) 1984-11-04
DK217184A (da) 1984-11-04
FI841759L (fi) 1984-11-04
KR840009098A (ko) 1984-12-24
EP0134400B1 (de) 1993-03-24
IL71664A (en) 1987-11-30
JPH0572391B2 (en, 2012) 1993-10-12
IL71664A0 (en) 1984-07-31
ES8603866A1 (es) 1986-01-16
EP0134400A3 (en) 1985-12-11
HU195220B (en) 1988-04-28
PT78518B (de) 1986-07-14
JPH0587508B2 (en, 2012) 1993-12-16
ES532149A0 (es) 1986-03-01
ZA843288B (en) 1984-12-24
DK217184D0 (da) 1984-05-01
AU2750084A (en) 1984-11-08
FI841759A0 (fi) 1984-05-03
GR79849B (en, 2012) 1984-10-31
JPH0586037A (ja) 1993-04-06
JPS59206379A (ja) 1984-11-22
NO841754L (no) 1984-11-05
AU579316B2 (en) 1988-11-24
DE3486109D1 (de) 1993-04-29
ES8604927A1 (es) 1986-03-01
ES545145A0 (es) 1986-01-16
PT78518A (de) 1984-06-01
ATE87311T1 (de) 1993-04-15
EP0134400A2 (de) 1985-03-20
US4555518A (en) 1985-11-26

Similar Documents

Publication Publication Date Title
NZ208023A (en) Heterocyclic fluoroalkoxy compounds and pharmaceutical compositions
US4758579A (en) Fluoroalkoxy substituted benzimidazoles useful as gastric acid secretion inhibitors
US4686230A (en) Picoline derivative useful as gastric acid secretion inhibitors
US4472409A (en) 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
US4689333A (en) 2-(2-pyridylmethylthio (sulfinyl)) benzimidazoles
US4560693A (en) [1,3]-Dioxolo[4,5-f]benzimidazoles and [1,4]-dioxino[2,3-f]benzimidazoles
EP0283504A1 (en) Compounds
JPS6122079A (ja) ジアルコキシピリジン及びそれを含有する薬剤
US5312824A (en) Certain 2-[(4-difluoromethoxy-2-pyridyl)-methylthio or methylsulfinyl-5-benzimidazoles useful for treating peptic ulcers
DE3415971A1 (de) Acylierte benzimidazole, verfahren zu ihrer herstellung, ihre anwendung und sie enthaltende arzneimittel
JPH0625151B2 (ja) ２−置換シクロヘプトイミダゾ−ル誘導体、抗潰瘍剤及びその製造方法
US5049674A (en) Therapeutically active fluoro substituted benzimidazoles
US5274099A (en) Therapeutically active fluoro substituted benzimidazoles
WO1986002645A1 (en) New amino compounds, preparation process thereof, utilization thereof and drugs containing them
NZ202386A (en) Substituted 2-pyridylmethyl(thio/sulphinyl)-benzimidazole derivatives and pharmaceutical compositions